Characteristics of peripheral Vγ2Vδ2 T cells in interferon-γ release assay negative pulmonary tuberculosis patients

被引:1
|
作者
Yan, Liping [1 ]
Shen, Hongbo [1 ]
Xiao, Heping [1 ]
机构
[1] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept TB, 507 Zhengmin Rd, Shanghai 200433, Peoples R China
来源
BMC INFECTIOUS DISEASES | 2018年 / 18卷
关键词
Pulmonary tuberculosis; V gamma 2V delta 2 T cells; Interferon-gamma release assays; T-SPOT.TB; MYCOBACTERIUM-TUBERCULOSIS; SKIN-TEST; INFECTION; DIAGNOSIS; RESPONSES; ACTIVATION; CHILDREN; IMMUNITY; SYSTEM; ANERGY;
D O I
10.1186/s12879-018-3328-x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: It is not fully explained why some active tuberculosis patients show negative interferon-gamma release assays (IGRAs). In this study, we tried to explore associations of IGRAs with the characteristics of peripheral V gamma 2V delta 2 T cells and their functions of producing cytokines. Methods: 32 pulmonary tuberculosis patients were enrolled and divided into two groups according to their IGRAs results: 16 with IGRA-negative as test group and 16 with IGRA-positive as control group. Chest X-rays and T-SPOT. TB tests were performed and the severity of the lung lesions was scored. The amount of V gamma 2V delta 2T cell and their expression levels of the apoptosis-related membrane surface molecule Fas and FasL in peripheral blood were analyzed by flow cytometry, and the function of secreting cytokines (IFN-gamma, TNF-alpha and IL-17A) of V gamma 2V delta 2 T cell were determined by intracellular cytokine staining. Results: The IGRA-negative TB patients had more lesion severity scores and displayed reduced peripheral blood V gamma 2V delta 2 T cell counts (p = 0.009) as well as higher Fas and FasL expression in peripheral blood V gamma 2V delta 2 T cells (p = 0. 043, 0.026). A high lesion severity score was correlated with a decreased V delta 2+ T cell number and increased V gamma 2V delta 2 T cells Fas/FasL expression leve in the peripheral blood (p = 0.00, P < 0.01). The function of secreting cytokines was slightly impaired in IGRA-negative TB patients (p = 0.402). There is no significant differences in expression levels of Fas and FasL in CD4+ T cells (p = 0.224, 0.287) or CD8+ T cells (p = 0.184, 0.067) between test and control groups. Conclusion: Compared with IGRA-positive TB patients, the IGRA-negative TB patients had more lesion severity scores, the number of V gamma 2V delta 2 T cells decreased and the function of secreting cytokines impaired. In addition, we suggest that increased expression of Fas/FasL triggers V gamma 2V delta 2 T cell apoptosis.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Phenotypic and functional alterations of Vγ2Vδ2 T cell subsets in patients with active nasopharyngeal carcinoma
    Puan, Kia Joo
    Low, John Seng Hooi
    Tan, Terence Wee Kiat
    Wee, Joseph Tien Seng
    Tan, Eng Huat
    Fong, Kam Weng
    Chua, Eu Tiong
    Jin, Chenggang
    Giner, Jose-Luis
    Morita, Craig T.
    Goh, Christopher Hood Keng
    Hui, Kam M.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (07) : 1095 - 1107
  • [42] Induction of ATM/ATR pathway combined with Vγ2Vδ2 T cells enhances cytotoxicity of ovarian cancer cells
    Lu, Jingwei
    Das, Manjusri
    Kanji, Suman
    Aggarwal, Reeva
    Joseph, Matthew
    Ray, Alo
    Shapiro, Charles L.
    Pompili, Vincent J.
    Das, Hiranmoy
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2014, 1842 (07): : 1071 - 1079
  • [43] CHARACTERIZATION OF INTERFERON-γ PRODUCING CELLS IN THE PERIPHERAL BLOOD OF PATIENTS WITH TUBERCULOSIS
    Ruiz-Sanchez, Bibiana Patricia
    Cruz-Zarate, David
    Hernandez-Solis, Alejandro
    Garcia-Paredes, Victor Gabriel
    Cicero-Sabido, Raul
    Serafin-Lopez, Jeanet
    Estrada-Garcia, Iris Citlali Elvira
    Wong-Baeza, Isabel
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [44] False-negative interferon-γ release assay results in active tuberculosis: a TBNET study
    de Visser, Veerle
    Sotgiu, Giovanni
    Lange, Christoph
    Aabye, Martine G.
    Bakker, Marleen
    Bartalesi, Filippo
    Brat, Kristian
    Chee, Cynthia B. E.
    Dheda, Keertan
    Dominguez, Jose
    Eyuboglu, Fusun
    Ghanem, Maha
    Goletti, Delia
    Dilektasli, Asli Gorek
    Guglielmetti, Lorenzo
    Koh, Won-Jung
    Latorre, Irene
    Losi, Monica
    Polanova, Monica
    Ravn, Pernille
    Ringshausen, Felix C.
    Rumetshofer, Rudolf
    de Souza-Galvao, Maria Luiza
    Thijsen, Steven
    Bothamley, Graham
    Bossink, Aik
    EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (01) : 279 - 283
  • [45] Control of CD56 expression and tumor cell cytotoxicity in human Vγ2Vδ2 T cells
    Urban, Elizabeth M.
    Li, Haishan
    Armstrong, Cheryl
    Focaccetti, Chiara
    Cairo, Cristiana
    Pauza, C. David
    BMC IMMUNOLOGY, 2009, 10 : 50
  • [46] Vγ2Vσ2 T Cells are Skewed Toward a Terminal Differentiation Phenotype in Untreated HIV Infection Reply
    Boudova, Sarah
    Li, Haishan
    Sajadi, Mohammad M.
    Redfield, Robert R.
    Cairo, Cristiana
    Pauza, C. David
    JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (01): : 184 - 184
  • [47] Characteristics Associated with Negative Interferon-γ Release Assay Results in Culture-Confirmed Tuberculosis Patients, Texas, USA, 2013-2015
    Nguyen, Duc T.
    Teeter, Larry D.
    Graves, Julie
    Graviss, Edward A.
    EMERGING INFECTIOUS DISEASES, 2018, 24 (03) : 534 - 540
  • [48] Synthesis of pyrophosphate-containing compounds that stimulate Vγ2Vδ2 T cells:: Application to cancer immunotherapy
    Tanaka, Y.
    Kobayashi, H.
    Terasaki, T.
    Toma, H.
    Aruga, A.
    Uchiyama, T.
    Mizutani, K.
    Mikami, B.
    Morita, C. T.
    Minato, N.
    MEDICINAL CHEMISTRY, 2007, 3 (01) : 85 - 99
  • [49] Erratum: Depletion and dysfunction of Vγ2Vδ2 T cells in HIV disease: mechanisms, impacts and therapeutic implications
    Haishan Li
    Suchita Chaudhry
    Bhawna Poonia
    Yiming Shao
    C David Pauza
    Cellular & Molecular Immunology, 2013, 10 : 283 - 283
  • [50] Control of CD56 expression and tumor cell cytotoxicity in human Vγ2Vδ2 T cells
    Elizabeth M Urban
    Haishan Li
    Cheryl Armstrong
    Chiara Focaccetti
    Cristiana Cairo
    C David Pauza
    BMC Immunology, 10